Video summary

Ditch 90% of Your Supplements (My Honest List After 10 Years)

Main summary

Key takeaways

Wellness and Self-Improvement

Key wellness/productivity takeaways

  • Avoid “supplement stacking” as a full-time job: The guidance argues that taking 20–40 pills/day can shift from optimization into an unnecessary daily hassle.
  • Use a systems-based, minimal routine: Build a broad but simple stack that supports core body functions instead of chasing endless add-ons.

Minimal, evidence-backed supplement routine (by goal/system)

Astaxanthin

Type: Antioxidant Targets: Skin anti-aging/UV protection, eye health, inflammation, lipids

Evidence highlights (as cited):

  • 2–12 mg/day improved skin moisturization and elasticity (2021 meta-analysis)
  • 4 mg/day reduced digital eye strain (2025 RCT)
  • 12+ weeks of >12 mg/day lowered hs-CRP (2020 meta-analysis)
  • Higher doses showed more consistent improvements in HDL; LDL reductions reported in another meta-analysis

Glycine + NAC

Type: Amino acids Targets: Antioxidant/glutathione support, inflammation, sleep, blood sugar/metabolic health, and (per discussion) muscle/mitochondrial function in older adults

Mechanism (as described):

  • Both support glutathione synthesis

Evidence highlights (as cited):

  • Glycine improved sleep (described mechanism: body temperature + inhibitory neurotransmitters)
  • In type 2 diabetes, glycine reduced HbA1c vs placebo and reduced inflammation (reported dose: 5 g, three times daily)
  • Acute glycine with glucose reduced post-meal glucose response by 50%+ (single-ingestion scenario described)

Practical guidance from the speaker:

  • If choosing between collagen vs glycine, choose glycine
  • Prefer both if possible, aiming roughly for:
    • Glycine: 5–10 g/day
    • Collagen peptides: ~10 g/day (noting collagen provides only part of total glycine)

Omega-3s

Targets: Long-term cardiovascular health, dementia/Alzheimer’s risk, endothelial/blood vessel function, blood lipids, inflammation

Key metric: omega-3 index

  • Suggested target: ~8% or higher

Evidence highlights (as cited):

  • Higher omega-3 index linked with lower mortality/heart disease risk (meta-analyses/studies described)
  • Higher DHA quintiles associated with lower Alzheimer’s risk (as described)

Creatine

Targets: Strength/power, high-intensity exercise performance

Evidence highlights (as cited):

  • Reported strength/performance improvements around 5–15%, especially with resistance training

Dosing guidance (as described):

  • Avoid huge doses (e.g., 20–30 g/day is unnecessary for typical goals)

Cautions / when to skip (as stated):

  • Avoid with kidney damage/suboptimal kidney function
  • Consider skipping if your priority is VO2 max adaptation
  • Consider skipping if you’re trying to look “super dry/diced” (water retention may cause puffiness)
  • No evidence mentioned that creatine causes hair loss (noting anecdotal reports)

Magnesium

Targets: Magnesium status, stress/anxiety, sleep quality, inflammation, energy production

Why it’s prioritized:

  • The speaker claims many people are deficient/insufficient

Evidence highlights (as cited):

  • Magnesium supplementation associated with lower blood pressure, inflammation, waist/body weight, improved insulin sensitivity, and better cholesterol profiles

Framing:

  • Magnesium is positioned as a “low-hanging fruit”/insurance policy if your diet isn’t diverse

Speaker’s “simplest” stack summary (as stated)

  • Astaxanthin + glycine → Skin
  • Astaxanthin + glycine + NAC + omega-3s → Inflammation
  • Glycine + magnesium → Blood sugar
  • Astaxanthin + omega-3s → Blood lipids
  • Creatine → Sports/fitness
  • Glycine + magnesium → Sleep

Optional add-ons + estimated cost

Optional

  • Vitamin D + Vitamin K2 if sunlight is limited (especially in northern locations)

Estimated cost

  • ~$50/month for the described stack (after initial purchase costs amortized over ~3–5 months)

Presenters/Sources

  • Video presenter: Not specified in the provided subtitles (no named individual; only self-references like “I personally…”)
  • Studies/meta-analyses cited (by year, as described):
    • 2021 systematic review/meta-analysis of RCTs (astaxanthin + skin)
    • 2025 randomized controlled trial (astaxanthin + digital eye strain in children)
    • 2020 meta-analysis of clinical trials (astaxanthin + hs-CRP/HDL/LDL effects as described)
    • 2021 meta-analysis (omega-3 index + total mortality risk)
    • 2022 study (omega-3 DHA quintile + Alzheimer’s risk)
  • No other named authors/journals/organizations are provided in the subtitles.

Original video